Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?

被引：3
|
作者：
Xu, Ke [1 ]
Chan, Noel C. C. [2 ,3 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China
[2] McMaster Univ, Dept Med, Div Hematol & Thromboembolism, Hamilton, ON, Canada
[3] 237 Barton St East, Hamilton, ON, Canada
来源：
THROMBOSIS AND HAEMOSTASIS | 2023年 / 123卷 / 05期
关键词：
RATES;
D O I：
10.1055/a-2015-8597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 489
页数：3
相关论文
共 50 条
  • [31] Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
    Lee, Mei-Chuan
    Liao, Chia-Te
    Feng, I-Jung
    Yu, Tsung
    Chang, Wei-Ting
    Shih, Mei-Fen
    Su, Hui-Chen
    Toh, Han Siong
    MEDICINE, 2022, 101 (37) : E30412
  • [32] Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment
    McBane, Robert D., II
    Vlazny, Danielle T.
    Houghton, Damon
    Casanegra, Ana, I
    Froehling, David
    Daniels, Paul
    Bin Riaz, Irbaz
    Hodge, David O.
    Wysokinski, Waldemar E.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 535 - 544
  • [33] Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
    Wåhlander, K
    Eriksson, H
    Lundström, T
    Clason, SB
    Wall, U
    Nyström, P
    Wessman, P
    Schulman, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (01) : 68 - 77
  • [34] Anticoagulation and Bleeding Risk in Elderly Patients with venous Thromboembolism (VTE)
    Thomas, H. -P.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S41 - S41
  • [35] A Nomogram for Predicting Cancer-Associated Venous Thromboembolism in Hospitalized Patients Receiving Chemoradiotherapy for Cancer
    Yan, Sisi
    Li, Genpeng
    Yao, Chen
    Song, Suting
    Tang, Rongying
    Du, Jiayi
    Zhang, Zhaoli
    Wang, Chunyu
    CANCER CONTROL, 2024, 31
  • [36] Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study
    Garcia-Garcia, Victor
    Barca-Hernando, Maria
    Lopez-Ruz, Sergio
    Rosa-Linares, Carmen
    Elias-Hernandez, Teresa
    Otero-Candelera, Remedios
    Gutierrez-Campos, David
    Andrade-Ruiz, Henry
    Carrier, Marc
    Jara-Palomares, Luis
    THROMBOSIS RESEARCH, 2025, 245
  • [37] ASSOCIATED FACTORS AFFECTING RECURRENCE OF VENOUS THROMBOEMBOLISM AND BLEEDING IN CANCER PATIENTS WITH VENOUS THROMBOEMBOLISM IN KOREA
    Kang, J. H.
    Gil, H. Y.
    Kim, Y. J.
    Lee, J. Y.
    VALUE IN HEALTH, 2019, 22 : S537 - S537
  • [38] Proper application of anticoagulation therapy on cancer-associated venous thrombosis
    Yhim, Ho-Young
    BLOOD RESEARCH, 2024, 59 (01)
  • [39] Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis
    Porfidia, Angelo
    Giordano, Marzia
    Sturiale, Carmelo L.
    D'Arrigo, Sonia
    Donadini, Marco P.
    Olivi, Alessandro
    Ageno, Walter
    Pola, Roberto
    BRAIN AND BEHAVIOR, 2020, 10 (06):
  • [40] Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
    Sogaard, Mette
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Kjaeldgaard, Jette Nordstrom
    Larsen, Torben Bjerregaard
    CANCER MEDICINE, 2019, 8 (03): : 1044 - 1053
12345